Compare EVO & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | CCSI |
|---|---|---|
| Founded | 1993 | 2021 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 778.3M | 683.1M |
| IPO Year | 2007 | 2022 |
| Metric | EVO | CCSI |
|---|---|---|
| Price | $1.82 | $36.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $7.00 | ★ $37.50 |
| AVG Volume (30 Days) | 41.4K | ★ 176.4K |
| Earning Date | 04-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.72 |
| Revenue | N/A | ★ $349,696,000.00 |
| Revenue This Year | $1.37 | $3.33 |
| Revenue Next Year | $10.05 | $2.70 |
| P/E Ratio | ★ N/A | $13.36 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.80 | $20.20 |
| 52 Week High | $4.27 | $41.40 |
| Indicator | EVO | CCSI |
|---|---|---|
| Relative Strength Index (RSI) | 39.03 | 49.46 |
| Support Level | N/A | $35.92 |
| Resistance Level | $1.97 | $40.12 |
| Average True Range (ATR) | 0.03 | 1.77 |
| MACD | 0.00 | -0.28 |
| Stochastic Oscillator | 17.65 | 46.09 |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in the fax cloud business. The company's offerings include communication, data extraction, and digital signature solutions that enable users to securely access, exchange, and manage information across organizational and geographic boundaries. It serves multiple industry verticals, including healthcare, government, financial services, legal, and education. Geographically, the company operates in the United States, Canada, Ireland, and other countries. It derives the maximum revenue from the United States.